Ken Griffin Pacific Biosciences Of California, Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 122,200 shares of PACB stock, worth $147,862. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122,200
Previous 119,400
2.35%
Holding current value
$147,862
Previous $140,000
7.86%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding PACB
# of Institutions
243Shares Held
199MCall Options Held
879KPut Options Held
847K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.3MShares$43.9 Million0.37% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$28.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$24.7 Million0.11% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA16.8MShares$20.3 Million2.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$19.4 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $272M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...